| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC2962 |
| Trial ID | NCT05277987 |
| Disease | Gastroesophageal Adenocarcinoma | Pancreatic Cancer |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HEC-016 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects |
| Year | 2022 |
| Country | China |
| Company sponsor | Shenzhen Fifth People's Hospital |
| Other ID(s) | HEC-016-GC/PC-101 |
| Cohort 1 | |||||||||
|
|||||||||